Other Updated 2022-02-03

BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion

See all recalls from BEOVU →
Share: Facebook X / Twitter WhatsApp

Recalled Product

BEOVU (brolucizumab)


✅ What Should You Do?

  1. ⚠️ Stop using this product until you have checked the recall details below.
  2. Follow the instructions from the issuing agency (see below).
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report a product safety incident to Health Canada
Looking for a safe alternative? Search Amazon Canada for BEOVU (brolucizumab) →

Hazard / Issue

New safety information - Product safety

Issued by

Marketed health products

View official government recall